BusinessPrecipio Launches ICE COLD-PCR™ Research Access Program for Cancer CentersBy Nasdaq OMXApr 11, 2018, 11:37 AM UTC
BusinessPrecision Therapeutics is the First Company to Grow Cancer Cells in the Lab That React Like Tumors Inside the Body -- CEOLIVE.TVBy Nasdaq OMXApr 4, 2018, 4:16 PM UTC
BusinessCrownBio to Showcase Scientific Expertise in Preclinical Drug Development at the American Association for Cancer Research (AACR) ConferenceBy Nasdaq OMXApr 4, 2018, 12:00 PM UTC
BusinessUnum Therapeutics Announces Closing of Initial Public Offering and Concurrent Private Placement with Seattle GeneticsBy Nasdaq OMXApr 3, 2018, 9:00 PM UTC
BusinessUnum Therapeutics Announces Pricing of Initial Public OfferingBy Nasdaq OMXMar 29, 2018, 1:35 AM UTC
BusinessActinium Pharmaceuticals Announces Collaborative Research Partnership with Astellas Leveraging Actinium’s AWE Platform TechnologyBy Nasdaq OMXMar 28, 2018, 12:01 PM UTC
BusinessINmune Bio’s Professor Mark Lowdell to Participate as Expert Speaker at the Third Annual Innate Killer Summit 2018By Nasdaq OMXMar 26, 2018, 12:30 PM UTC
